Panhematin is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Recordati Rare Diseases, Inc.. The primary component is Hemin.
Product ID | 55292-701_cdfd9947-bc51-43c9-9bd0-130c214bb68a |
NDC | 55292-701 |
Product Type | Human Prescription Drug |
Proprietary Name | Panhematin |
Generic Name | Hemin |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 1983-07-20 |
Marketing End Date | 2020-01-24 |
Marketing Category | BLA / BLA |
Application Number | BLA101246 |
Labeler Name | RECORDATI RARE DISEASES, INC. |
Substance Name | HEMIN |
Active Ingredient Strength | 7 mg/mL |
NDC Exclude Flag | N |
Marketing Start Date | 1983-07-20 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA101246 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1983-07-20 |
Marketing End Date | 2020-01-24 |
Marketing Category | BLA |
Application Number | BLA101246 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1983-07-20 |
Marketing End Date | 2020-01-24 |
Ingredient | Strength |
---|---|
HEMIN | 7 mg/mL |
SPL SET ID: | d84808a8-d039-6293-6e0d-782327f0a5c0 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
55292-701 | Panhematin | hemin |
55292-702 | Panhematin | hemin |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
PANHEMATIN 73451832 1317567 Live/Registered |
Abbott Laboratories 1983-11-07 |